report_description,report_link,report_date,report_mdufa_period,source,page,table_number,organization,org,program,table_title,metric_type,performance_metric,fy,value,status
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,116.54,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,117.76,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,118.68,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,141.02,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,138.42,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,43,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,49,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,43,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,60,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,57,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,87,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,89,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,106,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,101,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,120,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,119,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,127,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,148,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,147,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,175,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,197,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,190,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,225,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,232,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,159.5,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,158.03,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,162.86,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,157.86,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,134.37,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,91,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,90,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,75,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,125,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,126,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,126,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,120,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,99,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,172,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,163,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,182,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,170,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,141,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,238,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,250,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,250,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,242,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,209,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,110.55,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,107.57,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,111.38,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,127.35,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,121.29,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,52,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,50,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,53,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,58,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,58,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,84,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,86,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,88,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,110,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,106,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,105,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,130,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,121,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,163,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,162,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,164,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,209,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,183,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2013,98.6,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2014,98.61,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2015,97.2,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2016,95.23,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2017,107.14,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,37,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,32,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,30,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,29,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,30,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,72,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,77,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,60,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,62,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,62,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,90,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,101,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,96,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,98,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,100,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,137,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,141,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,146,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,138,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,162,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,146.51,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,151.28,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,152.3,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,176.54,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,169.01,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,79,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,84,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,82,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,103,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,106,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,99,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,116,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,114,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,148,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,154,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,150,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,179,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,190,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,241,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,242,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,241,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,261,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,263,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,136.48,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,137.61,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,164.65,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,177.31,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,162.25,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,51,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,56,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,58,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,64,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,102,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,98,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,118,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,123,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,118,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,150,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,148,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,166,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,190,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,180,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,228,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,227,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,250,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,265,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,256,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,150.61,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,173.83,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,187.01,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,188.1,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,169.73,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,64,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,90,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,113,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,140,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,139,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,150,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,131,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,177,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,205,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,216,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,208,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,181,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,248,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,261,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,266,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,263,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,256,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,122.86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,128.95,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,146.58,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,153.43,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,128.12,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,59,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,57,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,60,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,83,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,57,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,92,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,98,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,88,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,110,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,125,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,147,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,142,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,117,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,193,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,211,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,229,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,224,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,193,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,119.07,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,136.1,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,139.51,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,153.1,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,147.56,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,61,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,83,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,62,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,65,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,80,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,102,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,117,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,125,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,114,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,152,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,149,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,171,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,219,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,216,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,255,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,230,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,120.19,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,121.55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,121.51,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,126.46,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,123.89,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,57,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,56,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,38,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,48,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,54,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,86,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,67,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,64,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,80,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,115,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,111,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,103,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,111,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,116,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,189,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,185,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,184,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,199,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,213,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,131.25,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,118.28,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,251.45,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,338.69,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,291.28,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,31,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,58,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,148,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,158,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,88,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,67,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,91,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,237,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,210,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,134,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,90,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,238,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,381,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,330,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,235,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,194,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,476,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,511,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,436,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,91.81,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,101.4,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,108.41,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,123.1,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,124.01,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,30,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,28,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,29,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,48,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,51,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,58,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,59,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,63,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,80,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,93,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,103,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,114,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,118,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,132,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,138,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,165,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,167,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,193,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,199,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2023,112.64,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,60,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,114,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,156,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,110.17,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,30,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,86,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,121,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,169,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2023,122.54,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,59,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,130,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,190,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,97.08,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,56,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,79,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,90,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,133,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,114.96,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,53,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,86,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,119,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,183,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,82.75,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,57,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,85,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,117,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,97.26,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,60,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,89,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,153,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,101.7,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,60,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,111,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,153,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
